Isolated hyperthermic perfusion of extremities in malignant melanoma with melphalan and tumor necrosis factor
Kettelhack, C.; Hohenberger, P.; Schlag, P.M.
Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 113: 127-129
1996
ISSN/ISBN: 0942-2854 PMID: 9101810 Document Number: 465179
Isolated limb perfusion (ILP) with tumor necrosis factor (TNF) and melphalan was carried out in 21 patients with regionally metastatic malignant melanoma of the limbs. The observed response rate was 65% complete and 15% partial remission. These results warrant further investigation of ILP with TNF and melphalan vs ILP with melphalan alone in a prospective randomised multicenter trial.
Document emailed within 1 workday
Related Documents
Zwaveling, J.H.; Maring, J.K.; Mulder, A.B.; Bom, V.J.; van Ginkel, R.J.; Schraffordt Koops, H.; Girbes, A.R.; Hoekstra, H.J.; van der Meer, J. 1996: Effects of hyperthermic isolated limb perfusion with recombinant tumor necrosis factor alpha and melphalan on the human fibrinolytic system Cancer Research 56(17): 3948-3953Fraker, D.L.; Alexander, H.R.; Thom, A.K. 1994: Use of tumor necrosis factor in isolated hepatic perfusion Circulatory Shock 44(1): 45-50
Rosin, R.D.; Westbury, G. 1980: Isolated limb perfusion for malignant melanoma Practitioner 224(1348): 1031-1036
Broudy, V.C.; Harlan, J.M.; Adamson, J.W. 1987: Disparate effects of tumor necrosis factor-alpha/cachectin and tumor necrosis factor-beta/lymphotoxin on hematopoietic growth factor production and neutrophil adhesion molecule expression by cultured human endothelial cells Journal of Immunology 138(12): 4298-4302
Alsalameh, S.; Mattka, B.; Al-Ward, R.; Lorenz, H.M.; Manger, B.; Pfizenmaier, K.; Grell, M.; Kalden, J.R. 1999: Preferential expression of tumor necrosis factor receptor 55 (TNF-R55) on human articular chondrocytes: selective transcriptional upregulation of TNF-R75 by proinflammatory cytokines interleukin 1beta, tumor necrosis factor-alpha, and basis fibroblast growth factor Journal of Rheumatology 26(3): 645-653
Kroon, B.B.; Van Geel, A.N.; Benckhuijsen, C.; Wieberdink, J. 1987: Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs Anticancer Research 7(3 Part B): 441-442
Meyer, T.; Göhl, J.; Hohenberger, W. 1998: Locoregional recurrence of melanomas of the extremities after hyperthermic extremity perfusion: is reperfusion of value? Langenbecks Archiv für Chirurgie. Supplement. Kongressband. Deutsche Gesellschaft für Chirurgie. Kongress 115: 1452-1454
Hori, K.; Ehrke, M.J.; Mace, K.; Mihich, E. 1987: Effect of recombinant tumor necrosis factor on tumoricidal activation of murine macrophages: synergism between tumor necrosis factor and gamma-interferon Cancer Research 47(22): 5868-5874
He, S.; Huang, H. 1997: Monocyte tumor necrosis factor and tumor necrosis factor receptor expression in patients with alcoholic liver cirrhosis Zhonghua Nei Ke Za Zhi 36(8): 526-528
Hild, P.; Aigner, K.; Henneking, K. 1982: Levels of Cis-Platinum in hyperthermic isolated perfusion Anticancer Research 2(4): 255-256
Himeno, T.; Watanabe, N.; Yamauchi, N.; Maeda, M.; Tsuji, Y.; Okamoto, T.; Neda, H.; Niitsu, Y. 1990: Expression of endogenous tumor necrosis factor as a protective protein against the cytotoxicity of exogenous tumor necrosis factor Cancer Research 50(16): 4941-4945
Hild, P.; Aigner, K.; Schwemmle, K.; Henneking, K.; Illig, L.; Merker, G.; Hundeiker, M.; Paul, E.; Weber, E.G.; Müller, M. 1982: Tissue toxicity of cis-platinum in hyperthermic isolated extremity perfusion Anticancer Research 2(1-2): 17-22
Eigler, F.W.; Krause, U. 1997: Isolated hyperthermic extremity perfusion in soft tissue sarcoma Der Chirurg; Zeitschrift für Alle Gebiete der Operativen Medizen 68(6): 649
Bornscheuer, A.; Mahr, K.H.; Oldhafer, K.J.; Höltje, M.; Szabo, M.; Kirchhoff, S.K.; Seitz, W.; Kirchner, E. 1997: Anesthesiologic characteristics of isolated hyperthermic liver perfusion with mitomycin C Anaesthesiologie und Reanimation 22(5): 116-120
De Wilt, J.H.; Soma, G.; ten Hagen, T.L.; Kanou, J.; Takagi, K.; Nooijen, P.T.; Seynhaevel, A.L.; Eggermont, A.M. 2000: Synergistic antitumour effect of TNF-SAM2 with melphalan and doxorubicin in isolated limb perfusion in rats Anticancer Research 20(5b): 3491-3496
Kaneko, H.; Yamada, H.; Mizuno, S.; Udagawa, T.; Kazumi, Y.; Sekikawa, K.; Sugawara, I. 1999: Role of tumor necrosis factor-alpha in Mycobacterium-induced granuloma formation in tumor necrosis factor-alpha-deficient mice Laboratory Investigation; a Journal of Technical Methods and Pathology 79(4): 379-386
Graziosi, L.; Bugiantella, W.; Cavazzoni, E.; Donini, A. 2009: Laparoscopic intraperitoneal hyperthermic perfusion in palliation of malignant ascites. Case report Il Giornale di Chirurgia 30(5): 237-239
Pace, M.; Millanta, L.; Polignano, M.; Gattai, R.; Macera Mascitelli, E. 2005: Optimal procedure for thermal delivery in hyperthermic/chemotherapeutic treatments in the isolated perfusion of the the limbs Journal of Experimental and Clinical Cancer Research: Cr 24(1): 35-42
Oshiro, S.; Tsugu, H.; Komatsu, F.; Ohnishi, H.; Ueno, Y.; Sakamoto, S.; Fukushima, T.; Soma, G.-I. 2006: Evaluation of intratumoral administration of tumor necrosis factor-alpha in patients with malignant glioma Anticancer Research 26(6a): 4027-4032
Carrillo, E.H.; Gordon, L.E.; Richardson, J.David.; Polk, H.C. 2002: Free hemoglobin enhances tumor necrosis factor-alpha production in isolated human monocytes Journal of Trauma 52(3): 449-452